Matrifen® with silicon adhesion layer - pain relief from Nycomed

Matrifen® with its is silicone adhesion layer is indicated for patients with severe chronic pain such as cancer pain or low back pain.

Matrifen® with its silicone adhesion layer provides a membrane controlled release of fentanyl to ease severe chronic pain.

>> Information on Matrifen® with silicon adhesion layer

The transdermal patch Matrifen® with silicon adhesion layer releases fentanyl over a 72 hour period for fast and effective relief of pains such as cancer pain, low back pain, naturopathic pain, nociceptive pain and other chronic pains.

The transdermal fentanyl patch with silicon adhesion layer has been shown to have fewer side effects compared to morphine tablets and other oral formulations of opiod analgesics.

About Nycomed
Nycomed is a young company with a long history. Founded in 1874 in Norway by Morten Nyegaard, the company gradually began to expand into Europe, forming a strong position initially in the Nordic countries.

The modern story really begins in 1999, when Nycomed was established as a European company with a focus on sourcing and developing new pharmaceutical products. With this in place, the pace of this market expansion increased and the company now operates throughout Europe.

Postherpetic neuralgia | Transdermal fentanyl therapy | Opioid tolerance